Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
589,430,624
-
Share change
-
+50,208,746
-
Total reported value
-
$11,168,843,247
-
Put/Call ratio
-
145%
-
Price per share
-
$18.95
-
Number of holders
-
492
-
Value change
-
+$967,805,212
-
Number of buys
-
166
-
Number of sells
-
317
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q4 2017
As of 31 Dec 2017,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
492 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
589,430,624 shares.
The largest 10 holders included
Capital Research Global Investors, FRANKLIN RESOURCES INC, WELLINGTON MANAGEMENT GROUP LLP, HIGHFIELDS CAPITAL MANAGEMENT LP, BlackRock Inc., FMR LLC, Northern Cross, LLC, ABRAMS CAPITAL MANAGEMENT, L.P., Berkshire Hathaway Inc, and Brahman Capital Corp..
This page lists
492
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.